abrdn Life Sciences Investors
HQL
82 hedge funds and large institutions have $113M invested in abrdn Life Sciences Investors in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 7 closing their positions.
157% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 7
78% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 18
14% more funds holding
Funds holding: 72 → 82 (+10)
2.21% less ownership
Funds ownership: 34.7% → 32.49% (-2.2%)
9% less capital invested
Capital invested by funds: $125M → $113M (-$11.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$2.07M |
| 2 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
+$1.66M |
| 3 |
FHA
Flagship Harbor Advisors
Boston,
Massachusetts
|
+$1.22M |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$1M |
| 5 |
FAM
Formidable Asset Management
Cincinnati,
Ohio
|
+$866K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIA
Sit Investment Associates
Minneapolis,
Minnesota
|
-$5.47M |
| 2 |
SCM
Saba Capital Management
New York
|
-$3.27M |
| 3 |
AIA
Absolute Investment Advisers
Rosemary Beach,
Florida
|
-$2.81M |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$1.44M |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$1.2M |
HQL Hedge Fund Activity: Q1 2025 in Review
82 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q1 2025, worth a combined $113M — down 9.4% from $125M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new HQL positions and 7 closed out — a net gain of 11 holders — while 32 added to existing stakes and 18 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $2.07M. The largest seller was Sit Investment Associates, exiting entirely with an estimated $5.47M sold.
- 82 institutional investors held abrdn Life Sciences Investors (HQL) as of Q1 2025, up from 72 in Q4 2024.
- Funds reported $113M of abrdn Life Sciences Investors stock for Q1 2025, down 9.4% quarter-over-quarter.
- 18 funds opened new abrdn Life Sciences Investors positions in Q1 2025 and 7 closed out, a net change of +11 holders.
- The largest abrdn Life Sciences Investors buyer in Q1 2025 was Morgan Stanley, an estimated $2.07M added.
- The largest abrdn Life Sciences Investors seller in Q1 2025 was Sit Investment Associates, an estimated $5.47M sold.
Based on aggregated 13F filings for Q1 2025.